NeuBase Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q3 2010 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
NeuBase Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2010 to Q3 2023.
  • NeuBase Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2023 was 3.73M shares, a 88.7% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 3.73M -29.3M -88.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.88M -30.4M -94.2% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 33.8M +1.55M +4.81% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 1.66M -31.1M -94.9% Dec 31, 2022 10-Q 2023-11-09
Q3 2022 33M +287K +0.88% Sep 30, 2022 10-QT 2023-06-05
Q2 2022 32.3M -458K -1.4% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 32.3M +9.08M +39.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 32.8M +9.59M +41.4% Dec 31, 2021 10-Q 2022-02-11
Q3 2021 32.7M +9.57M +41.3% Sep 30, 2021 10-K 2022-12-21
Q2 2021 32.7M +9.6M +41.5% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 23.2M +6.1M +35.7% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 23.2M +20.3M +719% Dec 31, 2020 10-Q 2021-02-11
Q3 2020 23.2M +6.08M +35.6% Sep 30, 2020 10-K 2021-12-23
Q2 2020 23.1M +20.3M +717% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 17.1M +14.3M +504% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 2.83M 0 0% Dec 31, 2019 10-Q 2020-03-26
Q3 2019 17.1M +11.4M +198% Sep 30, 2019 10-K 2020-12-23
Q2 2019 2.83M -53.6M -95% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 2.83M -53.6M -95% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 2.83M -53.6M -95% Dec 31, 2018 10-Q 2019-02-14
Q3 2018 5.73M -50.5M -89.8% Sep 30, 2018 10-K 2020-01-10
Q2 2018 56.5M +255K +0.45% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 56.5M +20.5M +57% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 56.4M +20.5M +56.9% Dec 31, 2017 10-Q 2018-02-14
Q3 2017 56.2M +24.1M +75.2% Sep 30, 2017 10-K 2019-01-03
Q2 2017 56.2M +24.7M +78.4% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 36M +4.46M +14.2% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 36M +5.01M +16.2% Dec 31, 2016 10-Q 2017-02-14
Q3 2016 32.1M +1.75M +5.75% Sep 30, 2016 10-K 2017-12-15
Q2 2016 31.5M +1.17M +3.87% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 31.5M +1.54M +5.14% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 31M +5.69M +22.5% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 30.3M +5.08M +20.1% Sep 30, 2015 10-K 2016-12-22
Q2 2015 30.3M +5.47M +22% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 30M +8.16M +37.4% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 25.3M +5.3M +26.5% Dec 31, 2014 10-Q/A 2015-02-10
Q3 2014 25.3M +5.51M +27.9% Sep 30, 2014 10-K 2015-12-14
Q2 2014 24.9M Jun 30, 2014 10-Q 2014-08-18
Q1 2014 21.8M Mar 31, 2014 10-Q 2014-05-13
Q4 2013 20M Dec 31, 2013 10-Q 2014-02-14
Q3 2013 19.7M +3.99M +25.3% Sep 30, 2013 10-K 2014-12-22
Q3 2012 15.8M -23.9M -60.3% Sep 30, 2012 10-K 2013-12-27
Q1 2012 41.7M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 41.5M Dec 31, 2011 10-Q/A 2012-02-14
Q3 2011 39.7M +4.25M +12% Sep 30, 2011 10-Q 2012-05-11
Q2 2011 35.5M Jun 30, 2011 10-Q 2011-08-15
Q3 2010 35.5M Sep 30, 2010 10-K/A 2012-01-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.